Key points are not available for this paper at this time.
lesions during this term. Analysis of biopsied tissues by immunohistochemistry showed CD133+ cells were eliminated after CART-133 infusions. This trial showed the feasibility, controllable toxicities, and effective activity of CART-133 transfer for treating patients with CD133-postive and late-stage metastasis malignancies.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yao Wang
Chongqing University of Posts and Telecommunications
Meixia Chen
Xihu Institute of Electronic Research
Zhiqiang Wu
Dali University
OncoImmunology
Chinese PLA General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Wang et al. (Fri,) studied this question.
synapsesocial.com/papers/6a08876b7de338f10b10c297 — DOI: https://doi.org/10.1080/2162402x.2018.1440169
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: